Tumor cells have well-described strategies - using both a stealthy defense and a killing offense - for circumventing the immune system. New work now shows that highly metastatic cancer cells have yet another offensive strategy for killing lymphocytes.

On the defensive front, major histocompatibility complex (MHC) glycoproteins are involved in presenting antigens to cytotoxic T cells, and distinguishing self from non